Xylem Inc. (NYSE:XYL) was upgraded by research analysts at Janney Montgomery Scott from a “neutral” rating to a “buy” rating in a note issued to investors on Wednesday. The brokerage currently has a $52.00 target price on the stock, up from their previous target price of $50.00. Janney Montgomery Scott’s price target suggests a potential downside of 1.74% from the company’s previous close.
Several other equities analysts also recently issued reports on the stock. Atlantic Securities raised shares of Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 price objective on the stock in a report on Monday, August 22nd. Royal Bank Of Canada increased their price objective on shares of Xylem from $47.00 to $51.00 and gave the company an “outperform” rating in a report on Tuesday, August 16th. Zacks Investment Research downgraded shares of Xylem from a “buy” rating to a “hold” rating in a report on Friday, July 15th. Canaccord Genuity reaffirmed a “hold” rating and set a $50.00 price objective (up from $45.00) on shares of Xylem in a report on Tuesday, August 16th. Finally, Barclays PLC increased their price objective on shares of Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a report on Monday, July 18th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Xylem presently has an average rating of “Buy” and a consensus target price of $47.15.
Xylem (NYSE:XYL) traded up 0.11% during trading on Wednesday, hitting $52.92. 1,023,379 shares of the company were exchanged. Xylem has a 12 month low of $31.67 and a 12 month high of $54.99. The company has a market capitalization of $9.49 billion, a price-to-earnings ratio of 29.37 and a beta of 1.18. The stock’s 50-day moving average is $50.29 and its 200-day moving average is $48.28.
Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, November 1st. The company reported $0.54 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.01. The business had revenue of $897 million for the quarter, compared to the consensus estimate of $913.53 million. Xylem had a net margin of 8.83% and a return on equity of 16.38%. The company’s revenue was down .6% compared to the same quarter last year. During the same period last year, the firm posted $0.49 earnings per share. Equities research analysts anticipate that Xylem will post $2.04 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 7th. Shareholders of record on Wednesday, November 9th will be paid a dividend of $0.1549 per share. This represents a $0.62 annualized dividend and a yield of 1.17%. The ex-dividend date is Monday, November 7th. Xylem’s dividend payout ratio (DPR) is presently 34.44%.
In other Xylem news, SVP Claudia S. Toussaint sold 5,300 shares of the stock in a transaction dated Friday, November 4th. The shares were sold at an average price of $47.27, for a total transaction of $250,531.00. Following the completion of the transaction, the senior vice president now owns 44,033 shares of the company’s stock, valued at $2,081,439.91. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Colin R. Sabol sold 27,473 shares of the stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $50.91, for a total transaction of $1,398,650.43. Following the transaction, the insider now directly owns 65,530 shares of the company’s stock, valued at approximately $3,336,132.30. The disclosure for this sale can be found here. Company insiders own 0.77% of the company’s stock.
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Advisor Group Inc. bought a new position in shares of Xylem during the second quarter valued at $100,000. Mizuho Asset Management Co. Ltd. raised its position in Xylem by 122.1% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 2,323 shares of the company’s stock valued at $104,000 after buying an additional 1,277 shares during the last quarter. IFP Advisors Inc raised its position in Xylem by 113.6% in the second quarter. IFP Advisors Inc now owns 2,489 shares of the company’s stock valued at $111,000 after buying an additional 1,324 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in Xylem by 41.2% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,699 shares of the company’s stock valued at $120,000 after buying an additional 788 shares during the last quarter. Finally, Glenmede Trust Co. NA raised its position in Xylem by 9.4% in the second quarter. Glenmede Trust Co. NA now owns 2,908 shares of the company’s stock valued at $129,000 after buying an additional 250 shares during the last quarter. 84.62% of the stock is owned by institutional investors.
Xylem Company Profile